Mr. Yan Runbin (严润彬), the company’s chief operating officer, and he is primarily responsible for overseeing pre-clinical and corporate operations. Mr. Yan joined our Group in October 2016 and has held various positions in the PRC subsidiaries of the Company since then, including vice president, senior vice president and chief operating officer of Immvira Shenzhen and chief operating officer of Immvira Suzhou.

Mr. Yan has more than 20 years of experience in drug development and toxicology research. From March 2010 to July 2016, Mr. Yan served as the vice president of pharmaceutical department of Sunshine Lake Pharma Co., Ltd. (廣東東陽光藥業股份有限公司) and was responsible for drug safety evaluation. Mr. Yan worked at Sichuan Enwei Pharmacy Co., Ltd. (四川恩威製藥有限公司) from August 2005 to February 2010 and was responsible for conducting pharmacological and toxicological research.

Mr. Yan obtained his bachelor’s degree in clinical medicine from Chongqing Medical University (重慶醫科大學) in the PRC in June 2002. Mr. Yan then obtained his master’s degree in biomedical engineering in June 2005 from Chongqing University (重慶大學) in the PRC. Mr. Yan obtained qualification as a Senior Engineer in Biotechnology (生物技術高級工程師) issued by Ministry of Human Resources and Social Security of Shenzhen (深圳市人力資源和社會保障局) in October 2020.